This study is looking at whether a procedure called endovascular thrombectomy (using the AXS Catalyst Distal Access Catheter to remove a clot) is better than standard medical care alone for people who have had a specific type of stroke called a distal medium vessel occlusion (DMVO) ischemic stroke. You might be able to join if you are at least 18 years old and have had an acute ischemic stroke where other clot-busting treatments aren't suitable or haven't worked. The study aims to see if endovascular thrombectomy helps improve recovery 90 days after the stroke, as measured by a scale called the modified Rankin Scale. The study plans to enroll 584 participants, but its current status is unclear.

Study design

This is a Phase 3, randomized study where participants will be assigned by chance to either receive endovascular thrombectomy or standard medical care. It is an open-label study, meaning both you and your doctors will know which treatment you are receiving.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your recovery will be assessed 90 days after treatment to see how well you are doing.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.